Delivery Order SPE2DR25D2103-SPE2DR26F92CG

The Defense Logistics Agency issued a $8,555.21 delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for supply of Ibrance 125 mg capsules (21-count packages). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), a $999,999,999 vehicle through December 2026 that supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA. The order has a firm fixed price and an...

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for Ibrance 125 mg capsules (21-count), with a ceiling value of $8,555.21. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and running through December 2026.</p> <p>Place of performance is Conshohocken, PA 19428. Ultimate completion date is March 23, 2026. Pricing is firm fixed price. No set-aside was applied.</p>

The Defense Logistics Agency issued a $8,561.41 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for Ibrance 75 mg capsule 21-count units, with ultimate completion on March 26, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 that provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, PA. Pricing is firm fixed...

The Defense Logistics Agency issued a $25,665.63 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for supply of Ibrance 125 mg tablets (7s). This delivery order is issued under the DLA Troop Support Medical indefinite delivery contract (IDC) with Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 2026. The contract provides pharmaceutical and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken,...

The Defense Logistics Agency issued a $8,555.21 delivery order to Amerisourcebergen Drug Corp on March 3, 2026, for Ibrance 125 mg capsule supply (21-count packages), with completion required by March 24, 2026. Place of performance is Conshohocken, PA. The order was priced firm fixed price and carried no set-aside. This delivery order is issued against Amerisourcebergen Drug Corp's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...

The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for Ibrance 100 mg tablets. Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 10, 2026, and is priced as firm fixed price with no set-aside. The delivery order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supports pharmaceutical supply...

The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for Ibrance 100 mg tablets. Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 17, 2026. Pricing is firm fixed price. The order was issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through December 2026, which supports global pharmaceutical supply to military healthcare...

The Defense Logistics Agency issued an $8,555.21 delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for Ibrance 125 mg tablets (7-count). The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate...

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for Ibrance 125 mg capsule 21-count units, with a ceiling value of $8,555.21 and ultimate completion date of March 23, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is issued under a firm fixed-price structure with no set-aside applied.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 23, 2026, with a ceiling value of $8,555.21 for supply of Ibrance 125 mg capsules (21-count).</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is March 16, 2026. The order is priced on a firm fixed-price basis with no set-aside applied.</p>